France allocates additional US$11 million to Unitaid COVID-19 response

France pledged US$11 million to Unitaid as part of the Therapeutics Partnership (which is co-led by Unitaid and Wellcome Trust), as well as a part of the Access to COVID-19 Tools Accelerator (ACT-A) initiative co-coordinated by the World Health Organization.

France's financial support will support Unitaid's and Wellcome Trust's work, which aims to "develop, manufacture and distribute treatments for all stages of the disease; to prevent, suppress, treat and support recovery from COVID-19". The Therapeutics Partnership indicated that it is observing 1,700 trials and has identified several candidates, including antivirals and monoclonal antibodies. 

Press release - Unitaid